1-4 of 4
Marie-Josée Morin
Close
Sort by
Journal Articles

Oral Administration of PBI-1402 Significantly Reduces Erythropenia and Accelerates Peripheral Blood Recovery in Myeloablated Mice Post Transplantation.

Marie-Josée Morin, Gorazd Krosl, Mouna Lagraoui, Brigitte Grouix, Christopher Penney, Lyne Gagnon, Denis-Claude Roy
Journal: Blood
Blood (2006) 108 (11): 3201.
https://doi.org/10.1182/blood.V108.11.3201.3201
Published: 2006
Journal Articles

PBI-1402: A Low Molecular Weight Synthetic Hematopoietic Growth Stimulant.

Brigitte Grouix, Nathalie Julien, Mouna Lagraoui, Marie-Josée Morin, Gorazd Krosl, Denis-Claude Roy, Christopher Penney, Lyne Gagnon
Journal: Blood
Blood (2006) 108 (11): 4222.
https://doi.org/10.1182/blood.V108.11.4222.4222
Published: 2006
Journal Articles

PBI-1402: A New Candidate for the Treatment of Anemia.

Lyne Gagnon, Jean Barabé, Mouna Lagraoui, Brigitte Grouix, Nathalie Julien, Michel Asselin, Dannyck Gaudreau, François Sarra-Bournet, Boulos Zacharie, Christopher Penney, Pierre Laurin, Marie-Josée Morin, Gorazd Krosl, Denis-Claude Roy
Journal: Blood
Blood (2006) 108 (11): 4223.
https://doi.org/10.1182/blood.V108.11.4223.4223
Published: 2006
Journal Articles

PBI-1402: A Non-Toxic Immunorestorative Small Molecule for the Treatment of Anemia.

Mouna Lagraoui, Brigitte Grouix, Nathalie Julien, Michel Asselin, Dannyck Gaudreau, François Sarra-Bournet, Marie-Josée Morin, Gorazd Krosl, Denis-Claude Roy, Christopher Penney, Lyne Gagnon
Journal: Blood
Blood (2006) 108 (11): 4224.
https://doi.org/10.1182/blood.V108.11.4224.4224
Published: 2006